1. Home
  2. JXJT vs PSTV Comparison

JXJT vs PSTV Comparison

Compare JXJT & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JXJT
  • PSTV
  • Stock Information
  • Founded
  • JXJT 2012
  • PSTV 1996
  • Country
  • JXJT China
  • PSTV United States
  • Employees
  • JXJT N/A
  • PSTV N/A
  • Industry
  • JXJT Apparel
  • PSTV Medical/Dental Instruments
  • Sector
  • JXJT Consumer Staples
  • PSTV Health Care
  • Exchange
  • JXJT Nasdaq
  • PSTV Nasdaq
  • Market Cap
  • JXJT 8.1M
  • PSTV 10.4M
  • IPO Year
  • JXJT 2012
  • PSTV N/A
  • Fundamental
  • Price
  • JXJT $1.30
  • PSTV $1.77
  • Analyst Decision
  • JXJT
  • PSTV Strong Buy
  • Analyst Count
  • JXJT 0
  • PSTV 1
  • Target Price
  • JXJT N/A
  • PSTV $8.00
  • AVG Volume (30 Days)
  • JXJT 649.6K
  • PSTV 42.3K
  • Earning Date
  • JXJT 08-14-2024
  • PSTV 08-12-2024
  • Dividend Yield
  • JXJT N/A
  • PSTV N/A
  • EPS Growth
  • JXJT N/A
  • PSTV N/A
  • EPS
  • JXJT 0.48
  • PSTV N/A
  • Revenue
  • JXJT $31,840,588.00
  • PSTV $6,084,000.00
  • Revenue This Year
  • JXJT N/A
  • PSTV $5.21
  • Revenue Next Year
  • JXJT N/A
  • PSTV N/A
  • P/E Ratio
  • JXJT $2.71
  • PSTV N/A
  • Revenue Growth
  • JXJT N/A
  • PSTV 733.42
  • 52 Week Low
  • JXJT $1.04
  • PSTV $0.97
  • 52 Week High
  • JXJT $8.51
  • PSTV $3.21
  • Technical
  • Relative Strength Index (RSI)
  • JXJT 52.65
  • PSTV 48.74
  • Support Level
  • JXJT $1.20
  • PSTV $1.74
  • Resistance Level
  • JXJT $1.61
  • PSTV $1.97
  • Average True Range (ATR)
  • JXJT 0.21
  • PSTV 0.16
  • MACD
  • JXJT -0.00
  • PSTV 0.04
  • Stochastic Oscillator
  • JXJT 22.60
  • PSTV 55.22

About JXJT JX Luxventure Limited

JX Luxventure Ltd is engaged in the business of menswear, cross-border merchandise, airfare, and tourism. The company operates in three segments Tourism products, Technology and Cross- board merchandise. The majority of the group revenue is generated from the Tourism products.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: